These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 10950027)

  • 21. [Role of beta blockers in preventing hemorrhages from esophageal varices. A hemodynamic study].
    Santambrogio R; Galeotti F; Opocher E; Cucchiaro G; Cornalba GP; Rota L; Ferrario M; Fumagalli U; Spina GP
    Minerva Med; 1986 Mar; 77(12):429-32. PubMed ID: 2871526
    [No Abstract]   [Full Text] [Related]  

  • 22. [What is the treatment of choice in a patient with liver cirrhosis and esophageal varices that have bled to prevent rebleeding: beta-blockers, endoscopic ligation or both?].
    Albillos Martínez A
    Gastroenterol Hepatol; 2009 Feb; 32(2):124-5. PubMed ID: 19231689
    [No Abstract]   [Full Text] [Related]  

  • 23. [Medical therapy of portal hypertension due to liver cirrhosis].
    Cerini R; Sperandeo M; Varriale A; De Rosa ML; Cacciatore L
    Recenti Prog Med; 1991 Feb; 82(2):91-9. PubMed ID: 2034876
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [The effect of surgical treatment on hemodynamic and functional disorders in patients with liver cirrhosis].
    Loginov AS; Klemashev IS; Ershov IuA
    Vestn Khir Im I I Grek; 1972 Dec; 109(12):28-32. PubMed ID: 4664076
    [No Abstract]   [Full Text] [Related]  

  • 25. Use of non-selective beta blockers in cirrhosis: the evidence we need before closing (or not) the window.
    La Mura V; Tosetti G; Primignani M; Salerno F
    World J Gastroenterol; 2015 Feb; 21(8):2265-8. PubMed ID: 25741132
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [The effect of propranolol on portal hypertension].
    Kovacević N; Tomić D; Perisić-Savić M; Grbić R
    Srp Arh Celok Lek; 1992 Jun; 120 Suppl 4():62-4. PubMed ID: 18193814
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nonselective beta-blockers and hepatic venous pressure gradient monitoring: what lies behind nonresponse.
    Villanueva C; Aracil C; Colomo A; Balanzó J
    Gastroenterology; 2008 May; 134(5):1626-7; author reply 1627-8. PubMed ID: 18471536
    [No Abstract]   [Full Text] [Related]  

  • 28. [Use of esmolol in patient with portal hypertension].
    Figueroa Yusta J; Gilsanz F; De Dios Tomás E
    Rev Esp Anestesiol Reanim; 2001; 48(7):349. PubMed ID: 11591288
    [No Abstract]   [Full Text] [Related]  

  • 29. [Pathophysiological and pharmacotherapeutic aspects of portal hypertension].
    Sieber CC; Stalder GA
    Schweiz Med Wochenschr; 1993 Jan; 123(1-2):3-13. PubMed ID: 8093646
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Beta-adrenergic inhibitors and portal hypertension].
    Lebrec D
    Therapie; 1985; 40(6):403-6. PubMed ID: 2868535
    [No Abstract]   [Full Text] [Related]  

  • 31. Propranolol--a medical treatment for portal hypertension?
    Lebrec D; Nouel O; Corbic M; Benhamou JP
    Lancet; 1980 Jul; 2(8187):180-2. PubMed ID: 6105342
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [The pharmacologic treatment of portal hypertension].
    Guevara L
    Rev Gastroenterol Mex; 1984; 49(4):207-9. PubMed ID: 6152355
    [No Abstract]   [Full Text] [Related]  

  • 33. A1166C angiotensin II type 1 receptor gene polymorphism may predict hemodynamic response to losartan in patients with cirrhosis and portal hypertension.
    Sookoian S; Castaño G; García SI; Viudez P; González C; Pirola CJ
    Am J Gastroenterol; 2005 Mar; 100(3):636-42. PubMed ID: 15743363
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long term effects of propranolol on portal pressure in cirrhotic patients.
    Orban-Schiopu AM; Popescu CR
    Rom J Gastroenterol; 2003 Mar; 12(1):25-30. PubMed ID: 12673376
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of cimetidine on portal hypertension in cirrhotic patients.
    Burroughs AK; Walt R; Dunk A; Jenkins W; Sherlock S; Mackie S; Dick R
    Br Med J (Clin Res Ed); 1982 Apr; 284(6323):1159-60. PubMed ID: 6803877
    [No Abstract]   [Full Text] [Related]  

  • 36. Systematic review of HVPG measurement: statistics versus clinical applicability.
    Thalheimer U; Leandro G; Mela M; Patch D; Burroughs AK
    Gastroenterology; 2007 Mar; 132(3):1201-2; author reply 1202-4. PubMed ID: 17383448
    [No Abstract]   [Full Text] [Related]  

  • 37. Portal hypertension. Update on pathophysiology and management.
    Chatila R
    J Med Liban; 2001; 49(2):101-5. PubMed ID: 11910964
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Variceal bleeding and long-acting octreotide: a new addition to the armamentarium?
    Sanchez GA; Kubiliun N; Barkin JS
    Dig Dis Sci; 2008 Nov; 53(11):3046-7. PubMed ID: 18401715
    [No Abstract]   [Full Text] [Related]  

  • 39. Portal pressure response to losartan compared with propranolol in patients with cirrhosis.
    De BK; Bandyopadhyay K; Das TK; Das D; Biswas PK; Majumdar D; Mandal SK; Ray S; Dasgupta S
    Am J Gastroenterol; 2003 Jun; 98(6):1371-6. PubMed ID: 12818283
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Commentary on an abstract. Effects of metoclopramide and domperidone on azygous venous blood flow in patients with cirrhosis and portal hypertension].
    Sauerbruch T
    Z Gastroenterol; 1987 Sep; 25(9):612-3. PubMed ID: 3673147
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.